A controlled laboratory study published in Basic Research in Cardiology demonstrates that transplanting colitis-associated dysbiotic gut microbiota directly impairs cardiac contractility and triggers myocardial fibrosis in recipient mice through specific epigenetic modifications. While epidemiological observations have long linked inflammatory bowel disease to increased cardiovascular complications, the molecular mechanisms connecting intestinal bacterial perturbations to cardiac tissue injury have remained obscure. Working in controlled experimental models, researchers led by Rongliwen Ou and Qingjie Li at the University of Texas Medical Branch examined whether intestinal microbial communities harvested from colitic donor animals could induce cardiac pathology independently of severe systemic inflammatory signaling. Their findings establish that microbial disruption stimulates cardiac epigenetic changes that activate the transcription factor B-cell lymphoma and leukemia 11B, also designated as BCL11B, which subsequently accelerates fibroblast-like cellular proliferation and extracellular matrix accumulation in the heart.
To investigate whether gut dysbiosis directly alters myocardial performance, the researchers colonized two-month-old germ-free C57BL/6NTac mice of both sexes with pooled fecal slurries harvested from either six-month-old wild-type mice harboring a normal microbiome or age-matched homozygous interleukin-10 knockout mice that spontaneously develop chronic colitis accompanied by microbial dysbiosis. The fecal suspensions were prepared in fifteen percent glycerol in phosphate-buffered saline, filtered through sterile cotton gauze, and administered by oral gavage once a month for three consecutive months. By introducing these distinct bacterial populations into recipient mice that had never previously been exposed to microorganisms, the investigators created an isolated physiological system capable of determining whether the dysbiotic community itself, rather than underlying donor genetics or preexisting systemic inflammatory factors, is sufficient to trigger progressive morphological and functional damage within cardiac tissue.
Subsequent high-throughput profiling of cecal contents via 16S ribosomal RNA gene sequencing targeting the variable V3 to V4 region revealed that colonization with the dysbiotic microbiota substantially reshaped the intestinal ecosystem of recipient mice. Shannon entropy calculations demonstrated a statistically significant reduction in microbial alpha diversity among mice receiving dysbiotic microbiota compared to controls colonized with normal microbiota, a divergence driven primarily by female recipients. Principal coordinate analysis based on Canberra distance confirmed distinct structural clustering between recipient cohorts. Taxonomic evaluations revealed significant enrichment of the Eubacterium coprostanoligenes group, Marvinbryantia, and Butyricicoccus alongside profound depletion of beneficial commensals, including Clostridium sensu stricto 1, Alistipes, and Parabacteroides, together with health-associated bacterial families such as Muribaculaceae, Ruminococcaceae, and Clostridiaceae. Gas chromatography-mass spectrometry of circulating plasma revealed a selective and significant decline in plasma butyric acid levels in dysbiotic animals, while concentrations of acetic acid and propionic acid remained unaltered.
Functional evaluation of the recipient hearts by high-resolution transthoracic echocardiography using a thirty-megahertz probe identified pronounced systolic impairment in animals colonized with dysbiotic microbiota. M-mode and two-dimensional imaging demonstrated a significant increase in left-ventricular internal diameter at end-systole, while left-ventricular internal diameter at end-diastole remained unchanged relative to healthy microbiome recipients. Left-ventricular ejection fraction fell substantially from normal levels, showing a statistically significant reduction alongside corresponding decreases in fractional shortening and stroke volume. Notably, these functional deficits occurred in the absence of alterations in heart rate or left-ventricular mass. Histological analysis utilizing hematoxylin and eosin staining detected subtle interstitial edema and myofibril disorganization, while quantitative Sirius Red staining revealed marked accumulation of collagen fibers within the interstitial myocardial space, particularly around the aortic root, confirming the development of cardiac fibrosis without gross ventricular hypertrophy.
Importantly, the observed cardiac deterioration developed without a significant rise in circulating inflammatory cytokines. Enzyme-linked immunosorbent assays showed that systemic plasma levels of interleukin-6 and interleukin-1 beta were not significantly elevated in dysbiotic recipient mice of either sex. Within the middle colon, quantitative reverse transcription polymerase chain reaction indicated sex-dependent variations in local cytokine transcripts, including moderate increases in interleukin-1 beta and C-C motif chemokine ligand 2 in males and transforming growth factor-beta 1 in females, yet overall distal colon histological scores remained normal. Pathologist evaluations confirmed no significant differences in mucosal infiltration by neutrophils, mast cells, or eosinophils. These observations indicate that while the transplanted dysbiotic microbiome initiates modest, sex-influenced local colonic gene expression changes, the resulting cardiac phenotype arises independently of overt systemic inflammatory cascades.
To uncover the molecular mechanisms driving this fibrotic cardiomyopathy, the investigators performed bulk cardiac RNA-sequencing, which deposited expression profiles under accession GSE268069. Transcriptomic analysis identified thirty-seven differentially expressed genes in hearts from dysbiotic recipients, comprising twenty-nine significantly upregulated genes and eight downregulated genes, a pattern characteristic of widespread chromatin relaxation. Gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses highlighted overrepresented pathways associated with RNA polymerase II transcriptional activity, protein binding, cytokine receptor interactions, and histone acetyltransferase activity. Among the most prominent transcriptional changes was a greater than two-fold upregulation of the zinc-finger transcription factor Bcl11b, accompanied by significant induction of the epigenetic regulators N-acetyltransferase 8 family member 7, known as Nat8f7, and ten-eleven translocation methylcytosine dioxygenase 1, or Tet1, while circadian regulators such as Nr1d1 were significantly suppressed.
Subsequent biochemical and epigenetic assays confirmed that dysbiosis promotes a more transcriptionally permissive chromatin architecture across myocardial tissue. Nuclear extract evaluations demonstrated a significant elevation in overall histone acetyltransferase activity in dysbiotic hearts, whereas histone deacetylase activity remained steady, resulting in a marked increase in the ratio of acetyltransferase to deacetylase activity. Chromatin immunoprecipitation assays coupled with quantitative PCR revealed marked enrichment of acetylated histone H4 lysine 16 at the Bcl11b gene promoter. Concurrently, methylation-specific quantitative PCR demonstrated substantial hypomethylation of CpG islands within the Bcl11b promoter region. These dual epigenetic changes facilitated significantly greater recruitment of RNA polymerase II to the promoter locus, confirming that gut dysbiosis drives elevated Bcl11b expression in adult heart tissue through concerted promoter histone hyperacetylation and DNA demethylation.
In vitro mechanistic experiments in cultured C2C12 myoblasts validated the functional synergy between NAT8F7 and TET1 in driving Bcl11b transcription and collagen production. Transfecting cells with a mouse Bcl11b promoter-driven luciferase reporter demonstrated that expressing NAT8F7 or TET1 individually produced significant increases in promoter activity, while their co-expression generated an additive transcriptional activation. Chromatin immunoprecipitation experiments confirmed that both factors cooperatively augmented histone H4 lysine 16 acetylation and RNA polymerase II binding at the promoter. Furthermore, quantifying soluble procollagen type I N-terminal propeptide in the culture medium by enzyme-linked immunosorbent assay revealed that expressing NAT8F7 or TET1 stimulated collagen synthesis, with combined expression yielding the greatest propeptide secretion. Direct forced overexpression of Myc-DDK-tagged BCL11B markedly accelerated cell proliferation in MTT assays and increased secretion of procollagen propeptide along with protein levels of type I collagen alpha 1 chain, fibronectin 1, and brain-derived neurotrophic factor, while canonical regulators including transforming growth factor-beta remained unaltered.
The pathological relevance of these epigenetic and fibrotic pathways was further corroborated in an independent murine model of chronic colitis induced by cyclic dextran sodium sulfate administration. Eight-week-old C57BL/6J mice subjected to four repeating cycles of two percent dextran sodium sulfate exhibited substantial upregulation of cardiac Nat8f7, Tet1, and Bcl11b messenger RNA, mimicking the molecular signatures identified in germ-free mice receiving dysbiotic fecal transplants. Western blotting of ventricular tissue confirmed increased protein abundance of BCL11B, type I collagen alpha 1, transforming growth factor-beta, and galectin-3. Crucially, therapeutic intervention using fecal microbiota transplantation harvested from healthy donor mice and delivered at the end of each dextran sodium sulfate cycle reversed histone H4 lysine 16 hyperacetylation, restored promoter DNA methylation, suppressed excess RNA polymerase II recruitment, and normalized both BCL11B and profibrotic protein expression in the myocardium.
Despite providing direct evidence for a causative gut-heart signaling axis, the authors explicitly outlined several important experimental limitations that govern the interpretation of their findings. The primary in vivo model relied entirely on germ-free recipient animals colonized with microbiota from genetically manipulated interleukin-10-deficient donors, meaning the degree to which these findings generalize to conventionally housed animals with intact native microbiomes or antibiotic-preconditioned hosts remains untested. In addition, because murine and human intestinal microbiomes exhibit quantitative compositional differences, rodent colitis models may not fully reflect the immunological and microbiological heterogeneity observed in clinical inflammatory bowel disease. The authors also noted that cardiac phenotyping was conducted solely following the completion of three full monthly transplantation cycles, leaving the precise kinetics, early progression, and intermediate developmental stages of dysbiosis-induced myocardial remodeling undefined.
Finally, while the research identified key chromatin modifications directly regulating the Bcl11b promoter, the specific circulating bacterial metabolites and systemic signaling intermediaries that bridge gut dysbiosis to myocardial epigenetic machinery require further clarification. The authors proposed that the depletion of short-chain fatty acid producers and resulting declines in circulating butyrate may operate alongside dysregulated circulating microRNAs to alter cardiac chromatin status, but this synergistic mechanism remains an unproven hypothesis. Furthermore, cellular proliferation and extracellular matrix assays were conducted in C2C12 myoblasts in vitro, highlighting the need for future in vivo investigations using cardiomyocyte-specific and cardiac fibroblast-specific genetic manipulation models to conclusively establish cell-autonomous causality in living mammalian hearts.
Subject of Research: Epigenetic mechanisms linking colitis-induced gut microbial dysbiosis to myocardial fibrosis and systolic dysfunction
Article Title: Epigenetic activation of BCL11B is associated with profibrotic cardiac remodeling induced by colitis-associated gut dysbiosis
Article References: Ou, R., Zhong, X. S., Yu, C., Bugarini, G., Kochkarian, T., Lopez, K. M., Khanipov, K., Powell, D. W., Liu, X., & Li, Q. (2026). Epigenetic activation of BCL11B is associated with profibrotic cardiac remodeling induced by colitis-associated gut dysbiosis. Basic Research in Cardiology. https://doi.org/10.1007/s00395-026-01217-1
Image Credits: AI Generated
DOI: 10.1007/s00395-026-01217-1
Keywords: gut-heart axis, microbial dysbiosis, cardiac fibrosis, BCL11B, epigenetics, histone acetylation, DNA demethylation, fecal microbiota transplantation, inflammatory bowel disease, systolic dysfunction, TET1, NAT8F7, short-chain fatty acids, butyrate, myocardial remodeling, dextran sodium sulfate
